Agh Laveen LLC
Agh Laveen LLC was paid $4.04M by Medicaid between Jan 2018 and Dec 2024, across 77 billing codes. Its largest line is 99283, emergency room visit (moderate) — 34% of everything it billed.
GOODYEAR, AZ 85338
Next to other Emergency Care Clinic/Center providers in Arizona
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,702 | $164K | |
| 2019 | 1,079 | $115K | |
| 2020 | 246 | $46K | |
| 2021 | 226 | $45K | |
| 2022 | 10,926 | $667K | |
| 2023 | 26,345 | $1.50M | |
| 2024incomplete | 25,292 | $1.50M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 34% | 8,415 | 8,095 | $1.38M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 31% | 6,066 | 5,830 | $1.24M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 1,492 | 1,432 | $489K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 8.7% | 645 | 633 | $351K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 8.0% | 759 | 747 | $325K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.3% | 1,463 | 1,401 | $135K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.3% | 466 | 461 | $92K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 66 | 66 | $19K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 539 | 425 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,529 | 2,405 | $1K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,681 | 1,592 | $775.39 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,034 | 997 | $635.89 |
65 more codes
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 670 | $394.20 |
| 87631 | <1% | 1,128 | $257.51 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,326 | $247.38 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 580 | $175.00 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 842 | $168.43 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,011 | $153.28 |
| 81025 | <1% | 2,162 | $140.66 | |
| 80053 | Comprehensive metabolic panel | <1% | 4,192 | $108.14 |
| 71045 | Radiologic examination, chest; single view | <1% | 1,711 | $101.32 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 985 | $67.80 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 383 | $51.31 |
| 73130 | <1% | 93 | $49.78 | |
| 80306 | <1% | 38 | $27.28 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,133 | $26.93 |
| 82803 | <1% | 191 | $23.58 | |
| 83605 | <1% | 199 | $18.73 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,303 | $16.77 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,085 | $14.97 |
| 81003 | <1% | 2,803 | $14.35 | |
| 84484 | <1% | 841 | $8.39 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 253 | $7.15 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 195 | $4.93 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 716 | $4.58 |
| 82962 | <1% | 55 | $3.25 | |
| 82947 | <1% | 116 | $2.19 | |
| 73610 | 0% | 68 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 1,685 | $0.00 |
| 84520 | 0% | 117 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 717 | $0.00 |
| 90715 | 0% | 134 | $0.00 | |
| 84702 | 0% | 278 | $0.00 | |
| 80076 | 0% | 13 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 430 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 227 | $0.00 |
| 73630 | 0% | 114 | $0.00 | |
| 74018 | 0% | 55 | $0.00 | |
| 73030 | 0% | 13 | $0.00 | |
| 87634 | 0% | 190 | $0.00 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 0% | 51 | $0.00 |
| 73562 | 0% | 70 | $0.00 | |
| 82565 | 0% | 117 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 70 | $0.00 |
| 87186 | 0% | 13 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 29 | $0.00 |
| 93976 | 0% | 13 | $0.00 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 0% | 179 | $0.00 |
| 82550 | 0% | 253 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 135 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 4,256 | $0.00 |
| 82553 | 0% | 396 | $0.00 | |
| 80051 | 0% | 220 | $0.00 | |
| 85379 | 0% | 363 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 119 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 84 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 71 | $0.00 |
| A9270 | Non-covered item or service | 0% | 18 | $0.00 |
| 87077 | 0% | 26 | $0.00 | |
| 87428 | 0% | 27 | $0.00 | |
| 84703 | 0% | 107 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 886 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 38 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 14 | $0.00 |
| 96376 | 0% | 17 | $0.00 | |
| 76830 | Ultrasound, transvaginal | 0% | 12 | $0.00 |
| 76801 | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Agh Laveen LLC | Laveen, AZ | $109.33M |
| Agh Mesa LLC | Mesa, AZ | $28.01M |
| Agh Laveen LLC | Glendale, AZ | $14.88M |
| Agh Mesa LLC | Mesa, AZ | $4.69M |
| Agh Laveen LLC | Surprise, AZ | $3.48M |
| Agh Laveen LLC | Glendale, AZ | $3.40M |
| Agh Mesa LLC | Tempe, AZ | $3.34M |
| Agh Mesa LLC | Chandler, AZ | $2.76M |
| Agh Mesa LLC | Mesa, AZ | $2.66M |
| Agh Mesa LLC | San Tan Valley, AZ | $2.32M |
| Agh Mesa LLC | Phoenix, AZ | $1.74M |
| Agh Mesa LLC | Chandler, AZ | $1.12M |
| Agh Mesa LLC | Gilbert, AZ | $978K |
| Agh Laveen LLC | Mesa, AZ | $293K |
| Agh Laveen LLC | Chandler, AZ | $259K |
| Agh Laveen LLC | Phoenix, AZ | $184K |
| Agh Laveen LLC | Mesa, AZ | $167K |
| Agh Laveen LLC | Gilbert, AZ | $160K |
| Agh Laveen LLC | Chandler, AZ | $41K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.